Pharmacokinetics of ceftriaxone in patients undergoing continuous veno-venous hemofiltration

Journal of Clinical Pharmacology

Volumn 36, Issue 12, 1996, Pages 1114-1119

  Kroh, Udo Franz ^a   Lennartz, Herbert ^a   Edwards, David J ^b   Stoeckel, Klaus ^c  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b WAYNE STATE UNIVERSITY   (United States)

^c CLINPHARM SUPPORT GmbH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE;

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DISEASE SEVERITY; DRUG CLEARANCE; DRUG HALF LIFE; FEMALE; HEMOFILTRATION; HUMAN; KIDNEY CLEARANCE; MALE;

EID: 0030481496     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1552-4604.1996.tb04164.x     Document Type: Article

References (13)

1. Kaplan AA, Longnecker RE, Folkert VW: Continuous arteriovenous hemofiltration, a report of six months' experience. Ann Intern Med 1984;100:358-367.
2. Golper TA, Bennett WM: Drug removal by continuous arteriovenous haemofiltration: a review of the evidence in poisoned patients. Med Toxicol 1988;3:341-349.
3. Golper TA: Drug removal during continuous hemofiltration of hemodialysis. Contrib Nephrol 1991;93:110-116.
4. Vesconi S, Sicignano A, De Pietri P, Foroni C, Minuto A, Bellato V, Riboni A: Continuous veno-venous hemofiltration in critically ill patients with multiple organ failure. Int J Artif Organs 1993;16:592-598.
5. Kroh UF, Holl TJ, Steinhäußer W: Management of drug dosing in continuous renal replacement therapy. Semin in Dial 1996; 9:161-165.
6. Kroh UF, Lennartz H: Evaluation and first validation study on a simplified drug dosage algorithm for multiple organ failure patients. Ren Fail 1992;14:579-585.
7. Lau AH, Pyle K, Kronfol NO, Libertin CR: Removal of cephalosporins by continuous arteriovenous ultrafiltration (CAVU) or hemofiltration (CAVH). Int J Artif Organs 1989;12:379-383.
8. De'Clari F: Ceftriaxone pharmacokinetics during continuous arteriovenous haemofiltration. J Antimicrob Chemother 1991; 27:394-396.
9. Trautmann KH, Haefelfinger P: Determination of Ro 13-9904 in plasma, urine and bile by means of ion-pair reversed phase chromatography. J High Resolution Chromatogr Commun 1981;4:54-59.
10. Patel IH, Sugihara JG, Weinfeld RE, Wong EGC, Siemsen AW, Berman SJ: Ceftriaxone pharmacokinetics in patients with various degrees of renal impairment. Antimicrob Agents Chemother 1984;25:438-442.
11. Stoeckel K, McNamara PJ, Brandt R, Plozza-Nottebrock H, Ziegler WH: Effects of concentration-dependent plasma protein binding on Ceftriaxone kinetics. Clin Pharmacol Ther 1981; 29:650-657.
12. Stoeckel K, McNamara PJ, Hoppe-Seyler G, Blumberg A, Keller E: Single-dose Ceftriaxone kinetics in functionally anephric patients. Clin Pharmacol Ther 1983;33:633-641.
13. Koup JR, Keller E, Neumann H, Stoeckel K: Ceftriaxone pharmacokinetics during peritoneal dialysis. Eur J Clin Pharmacol 1986;30:303-307.